Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
662-03-013 ISMRM Abstract

Prediction of Lymphatic Metastatic Risk in Rectal Cancer Using MRI-DKI Habitat Radiomic Features and Clinical Immune Markers

Primary: Body - Digestive
Secondary: Diffusion
662-03-013 · Classification: Other Cancer · Thursday, 14 May, 1:40 PM–2:35 PM · Digital Posters Row C
Keywords: Rectal cancer Habitat radiomics Diffusion kurtosis imaging 3.0T magnetic resonance imaging Lymphatic metastasis
Accepted
Leping Peng 1, Rong Li1, Ke Hai1, Fan Zhang1, Fang Ma1, Xiuling Zhang1, Kai AI2, Lili Wang3
1Gansu University of Chinese Medicine, Lanzhou, China
2Department of Clinical and Technical Support, Philips Healthcare (Xi'an), Xi'an, China
3Department of Radiology, Gansu Provincial Hospital, Lanzhou, China
Presenting Author: Leping Peng

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229-263. doi.org/10.3322/caac.21834 [doi]
2. Benson AB, Venook AP, Al-Hawary MM et al (2022) Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20:1139-1167. doi.org/10.6004/jnccn.2022.0051 [doi]
3. Chen L, Hu H, Yuan Y, Weng S (2024) CSCO guidelines for colorectal cancer version 2024: Updates and discussions. Chin J Cancer Res 36:233-239. doi.org/10.21147/j.issn.1000-9604.2024.03.01 [doi]
4. Chandramohan A, Mittal R, Dsouza R et al (2022) Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer. Colorectal Dis 24:428-438. doi.org/10.1111/codi.16032 [doi]
5. Granata V, Fusco R, Reginelli A et al (2019) Diffusion kurtosis imaging in patients with locally advanced rectal cancer: current status and future perspectives. J Int Med Res 47:2351-2360. doi.org/10.1177/0300060519827168 [doi]
6. Hu S, Peng Y, Wang Q et al (2022) T2*-weighted imaging and diffusion kurtosis imaging (DKI) of rectal cancer: correlation with clinical histopathologic prognostic factors. Abdom Radiol (NY) 47:517-529. doi.org/10.1007/s00261-021-03369-1 [doi]
7. Kratz F (2008) Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132:171-183. doi.org/10.1016/j.jconrel.2008.05.010 [doi]
8. Kildusiene I, Dulskas A, Smailyte G (2024) Value of combined serum CEA, CA72-4, and CA19-9 marker detection in diagnosis of colorectal cancer. Tech Coloproctol 28:33. doi.org/10.1007/s10151-023-02873-4 [doi]
9. Jardim-Perassi BV, Huang S, Dominguez-Viqueira W et al (2019) Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models. Cancer Res 79:3952-3964. doi.org/10.1158/0008-5472.Can-19-0213 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/662-03-013